NFE2 and cancer: At the same time, there is also evidence that c-MYC levels progressively increase with age, leading to an age-dependent decrease in Nrf2 (nuclear factor erythroid 2 (NFE2)-related factor 2) signaling and adaptive homeostasis, thereby minimizing age-dependent cancer incidence [65].